Autophagy (Lecture 2)

Slide 1 · Autophagy

Cellular self-digestion, stress adaptation and the paradox of cancer survival

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · What this lecture will establish

Describe the formation and lysosomal maturation of an autophagosome.

Explain why recycling supports cells during nutrient deprivation and hypoxia.

Distinguish tumor-suppressive from tumor-supportive effects of autophagy.

Relate autophagy to growth metabolism, dormancy and therapeutic resistance.

Slide 3 · Autophagy is a cellular survival decision

Nutrient or oxygen stress

Self-digestion of cell constituents

Recycled metabolites

Temporary survival

Starved cells arrest growth while salvaging carbon and essential metabolites.

If the adaptation cannot sustain viability, the cell may die.

Slide 4 · Definition: Lysosome-mediated self-digestion

Autophagy delivers cytoplasmic material to lysosomes for degradation.

“Self-eating” describes utilization of intracellular contents, not engulfment of another cell.

The resulting breakdown products re-enter cellular metabolism.

Slide 5 · What can enter the autophagic pathway?

Structural material

Damaged or obsolete organelles

Membrane material

Cytoplasmic constituents

Macromolecular cargo

Aggregated proteins

Protein complexes

Intracellular debris

Recovered value

Smaller metabolites

Substrates for maintenance

Carbon for energy production

Slide 6 · Nutrient deprivation is a major trigger

Decline in nutrient supply

Growth arrest and stress sensing

Autophagy induction

Metabolite recovery

Autophagy is evolutionarily conserved as an adaptive response to starvation.

Its survival benefit is especially apparent when external substrates are scarce.

Slide 7 · Hypoxia creates parallel metabolic pressure

Cells under inadequate oxygen supply experience metabolic stress.

Hypoxia as a pathologic trigger of autophagy.

Autophagy can help sustain function by recovering intracellular substrates.

Slide 8 · Autophagy also responds to nonnutritional stress

Physiologic settings

Aging

Exercise

Turnover of aging cell structures

Pathologic settings

Oxidative stress

Organelle or membrane damage

Hypoxia and limited nutrients

Slide 9 · Stress response is not unlimited rescue

Stress

Autophagic adaptation

Insufficient substrate salvage

Starvation-associated death

Recycling delays injury when external nutrients cannot meet cellular needs.

Autophagy does not guarantee indefinite survival under persistent severe stress.

Slide 10 · Autophagy is one route to the lysosome

Autophagy

Intracellular organelles and aggregates

Double-membrane autophagosome

Fusion with lysosome

Heterophagy

Material acquired from outside the cell

Endosome or phagosome

Fusion with lysosome

Slide 11 · Autophagy and proteasomal degradation differ

Autophagic–lysosomal route

Captures organelles or larger assemblies

Membrane enclosure precedes digestion

Lysosomal enzymes degrade contents

Ubiquitin–proteasome route

Processes many cytosolic proteins

Ubiquitin marks target proteins

Proteasomal complexes generate peptides

Slide 12 · Three core compartments organize the process

Isolation membrane

Autophagosome

Autophagolysosome

Recycled metabolites

A forming membrane sequesters cargo before lysosomal digestion.

The final vesicle is a processing compartment rather than a permanent store.

Slide 13 · Phagophore: The isolation membrane

Growing isolation membrane

The phagophore is an early isolation membrane that curves around cytoplasmic cargo.

It enlarges before closing into a complete vesicle.

Schematic: Membrane arrangement, not a histologic specimen.

Slide 14 · The endoplasmic reticulum is a membrane source

The endoplasmic reticulum as a probable source of isolation membrane.

Plasma membrane and mitochondrial membranes may also contribute.

The phagophore therefore originates within the cell’s membrane system.

Slide 15 · ATG proteins regulate assembly in sequence

Environmental signals

Initiation complex

Hierarchical ATG recruitment

Membrane nucleation

More than 30 autophagy-related (ATG) genes.

Their products coordinate creation of an autophagosome.

Slide 16 · Initiation responds to environmental cues

Nutrient deprivation and reduced growth-factor stimulation activate autophagy initiation.

An initiation complex recruits the proteins required to assemble the isolation membrane.

This is a regulated program, not uncontrolled membrane fragmentation.

Slide 17 · Nucleation creates a membrane platform

Initiation complex

Nucleation complex

Isolation membrane

Cargo-engulfing phagophore

Nucleation establishes the membrane region that will grow around material.

Subsequent expansion requires additional ATG-dependent reactions.

Slide 18 · Elongation progressively sequesters cargo

Growing isolation membrane

The open membrane expands around organelles and cytosolic structures.

Continued elongation eventually enables membrane closure.

Enclosure separates future digestive cargo from surrounding cytoplasm.

Slide 19 · LC3 lipidation helps build the autophagosome

LC3

Conjugation to PE

Lipidated LC3 on membrane

Membrane elongation / closure

Two ubiquitin-like conjugation systems participate in membrane expansion.

Phosphatidylethanolamine (PE) is covalently linked to LC3.

Slide 20 · LC3 has a structural and tracking role

Lipidated LC3 contributes to enclosure of the forming autophagosome.

The amount of PE-linked LC3 increases during autophagy.

LC3 as a useful marker for recognizing autophagy-related structures.

Slide 21 · Closure forms a double-membrane autophagosome

Sequestered cytoplasmic cargo

After enclosure, captured cytoplasm lies within a sealed double-membrane vesicle.

Cytoplasmic organelles and other structures can be enclosed.

The autophagosome must mature before its contents are degraded.

Slide 22 · Lysosome fusion is necessary for maturation

Autophagosome

Lysosome

The newly formed autophagosome fuses with the lysosomal compartment.

The resulting autophagolysosome gains access to hydrolytic enzymes.

Fusion connects sequestration to actual cargo destruction.

Slide 23 · Lysosomal hydrolases digest the contents

Lysosomal hydrolase action

The inner autophagosomal membrane and sequestered contents are degraded.

Lysosomal enzymes convert complex cellular material into smaller products.

The process supports recovery rather than simple intracellular storage.

Slide 24 · Recycled metabolites support continued function

Intracellular cargo

Lysosomal breakdown

Released metabolites

Maintenance and energy needs

Cells can use recovered material when supply from the environment is limited.

This is a catabolic contribution to cellular energy and substrate balance.

Slide 25 · The complete pathway is a staged process

Initiation / nucleation

Phagophore expansion

Sealed autophagosome

Lysosomal degradation

Recycling

Sequestration and degradation are mechanistically distinct stages.

The pathway depends on organized membrane trafficking and lysosomal function.

Slide 26 · Autophagic cargo selection is not wholly random

That autophagy can selectively capture cytoplasmic targets.

Lipidated LC3 participates in targeting aggregates and obsolete organelles.

Target selection helps remove constituents that threaten cellular integrity.

Slide 27 · Autophagy supports organelle quality control

Examples of turnover

Endoplasmic reticulum

Mitochondria

Lysosomes

Functional consequence

Removes worn or damaged structures

Maintains intracellular organization

Supports cellular stress tolerance

Slide 28 · Intracellular aggregates can be removed

Aggregate accumulation

Selective cargo targeting

Autophagosome capture

Lysosomal clearance

Stress and aging can increase intracellular protein aggregates.

Autophagic clearance is one mechanism that limits this burden.

Slide 29 · Atrophic cells use nutrient salvage

Autophagy is prominent in cells undergoing severe nutrient deprivation.

Self-digestion supports maintenance even while cell mass is being lost.

Atrophy and adaptive recycling may therefore coexist.

Slide 30 · LC3 positivity requires cautious interpretation

What the source supports

LC3 is linked to autophagosome membranes

Lipidated LC3 increases during autophagy

It is useful as an autophagy marker

What a static observation cannot establish by itself

How much material was fully degraded

Whether fusion with lysosomes succeeded

Whether autophagy benefits a particular tumor

Slide 31 · Prolonged severe stress can overwhelm adaptation

Persistent cellular stress

Autophagy increases

Protective capacity exceeded

Cell death pathways may activate

Excessive autophagy settings to apoptosis, necroptosis and ferroptosis.

These associations do not prove autophagy directly caused cell death.

Slide 32 · Autophagy-associated death remains mechanistically debated

Cell death can accompany marked or prolonged autophagic activity.

The responsible insult may be the original stressor rather than the autophagic process.

Do not equate the observation of autophagosomes with an established cause of death.

Slide 33 · Disease associations extend beyond neoplasia

Disease context

Neurodegenerative disorders

Infectious diseases

Inflammatory bowel diseases

Cancer

Autophagy-related concern

Defective proteostasis and turnover

Microbial degradation and host defense

Genetic susceptibility associations

Both suppression and survival benefit

Slide 34 · Neurodegeneration links clearance to proteostasis

Impaired organelle turnover can aggravate neuronal dysfunction.

Abnormal protein handling becomes more important in long-lived cells.

Defective autophagy with several neurodegenerative disorders.

Slide 35 · Alzheimer disease: Maturation can be impaired

Autophagosome formation

Impaired maturation

Poor cargo clearance

Contributions to neuronal stress

Robbins specifically describes impaired autophagosome maturation in Alzheimer disease.

Genetic autophagy defects accelerate neurodegeneration in cited mouse models.

Slide 36 · Autophagy contributes to control of intracellular pathogens

Intracellular microbe

Autophagic capture

Lysosomal degradation

Antigen processing / defense

The source cites mycobacteria, Shigella species and HSV-1 as examples.

Autophagy can deliver microbial material to antigen-presentation pathways.

Slide 37 · Inflammatory bowel disease has an ATG16L1 association

Genome-wide association studies link ATG16L1 variants with Crohn disease and ulcerative colitis.

The precise mechanism promoting intestinal inflammation is unknown.

Genetic association does not automatically establish a complete causal mechanism.

Slide 38 · Normal autophagy integrates catabolism and quality control

During limited nutrients

Recovers carbon and metabolites

Buffers acute metabolic deprivation

Helps maintain cellular viability

During cellular damage

Eliminates damaged organelles

Disposes of aggregates

Supports intracellular homeostasis

Slide 39 · Cancer cells confront an unstable microenvironment

Tumor cells often encounter limited nutrients and hypoxia.

Their growth demands biosynthetic material while stress threatens survival.

Autophagy may be helpful, dispensable or suppressed depending on tumor context.

Slide 40 · Some tumors appear to evade autophagy induction

Marginal environment

Expected autophagy signal

Pathway not activated

Continued tumor growth

Tumors that grow under marginal conditions without triggering autophagy.

This raises the possibility of impaired autophagy-inducing pathways.

Slide 41 · Certain pro-autophagy genes act as tumor suppressors

The source identifies a subset of genes promoting autophagy as tumor suppressors.

Loss of such functions may enhance tumor growth.

The excerpt does not justify claiming that every autophagy gene is tumor suppressive.

Slide 42 · Reduced autophagy can favor tumor development

Loss of a protective pathway

Defective stress / damage handling

Selection of surviving abnormal cells

Potential growth advantage

Autophagy loss as one plausible cancer-promoting mechanism.

This is a context-dependent model, not a universal causal sequence.

Slide 43 · Autophagy can also be a tumor survival mechanism

Limited nutrients or hypoxia

Autophagy-mediated recycling

Metabolic support

Survival in adverse conditions

Cancer cells can use the same nutrient-salvage program as normal cells.

This survival function complicates the concept of autophagy as purely tumor-suppressive.

Slide 44 · Tumor dormancy creates a prolonged survival state

Dormancy as hibernation-like survival during adverse conditions.

Autophagy may sustain quiescent cancer cells through prolonged hardship.

Persistence need not be accompanied by active tumor-cell division.

Slide 45 · Dormant cells may evade proliferation-targeting treatment

Dormant cell state

Low proliferative activity

Reduced susceptibility to drugs killing dividing cells

Potential persistence

This is a proposed explanation for some treatment failures in the source.

The textbook uses cautious language: Such cells are believed to be resistant.

Slide 46 · Autophagy may be a friend or a foe of a tumor

Autophagy in cancer

Tumor-suppressive setting

Protective genes oppose tumor development

Loss can support growth

Effect varies across tumors

Tumor-supportive setting

Recycling under metabolic stress

Support of long-term dormancy

Potential treatment persistence

Slide 47 · Tumor context determines the net effect

The consequences depend on the molecular wiring of regulatory pathways.

The same autophagic machinery may have opposing roles at different tumor stages.

A binary “autophagy always promotes cancer” claim contradicts Robbins.

Slide 48 · Two hypothetical tumors can behave differently

Tumor model A

Protective autophagy induction is defective

Loss may favor tumor growth

Restoring protection is conceptually relevant

Tumor model B

Severe nutrient stress persists

Autophagic recycling sustains viability

Blocking adaptation could have different effects

Slide 49 · A static LC3 result cannot assign tumor prognosis

LC3 is useful for recognizing autophagy-related structures, not a stand-alone cancer behavior score.

A tumor’s clinical phenotype depends on pathway context.

The supplied excerpt provides no validated diagnostic cutoff or predictive threshold.

Slide 50 · Pro-growth metabolism is the adjacent context

Growth-driven state

Uptake of glucose and glutamine

Biosynthesis of nucleotides, proteins and lipids

Oncogenic growth signaling

Nutrient-stressed state

Reduced available external substrates

Growth arrest / adaptation

Autophagic salvage of intracellular carbon

Slide 51 · Aerobic glycolysis supports biosynthesis

Increased glucose uptake

High glycolytic flux

Intermediate metabolites

Macromolecule production

The Warburg effect is aerobic glycolysis in growing cells.

This program is not unique to malignant cells.

Slide 52 · Growing cells need carbon skeletons, not only ATP

A dividing cell must duplicate nucleic acids, proteins, lipids and organelles.

Glycolytic and mitochondrial intermediates supply biosynthetic precursors.

This helps explain the metabolic program of rapidly proliferating cells.

Slide 53 · PI3K–AKT signaling amplifies anabolic metabolism

Growth-factor receptor

PI3K / AKT pathway

Increased glucose use

Lipids and proteins for growth

PI3K–AKT signaling to increased glucose transport and glycolysis.

The same pathway supports lipid and protein synthesis.

Slide 54 · MYC reinforces the growth-metabolism program

Pro-growth signals

MYC expression

Glycolytic enzymes / glutaminase

Anabolic supply

MYC promotes gene expression supporting glycolysis and glutamine metabolism.

These effects support the biomass requirements of growing cells.

Slide 55 · Tumor suppressors oppose progrowth metabolism

Pro-growth drivers

RTK / PI3K / AKT

MYC

Oncogenic signaling

Counterbalancing factors

PTEN opposes PI3K–AKT

P53 restrains anabolic routes

STK11 antagonizes metabolic changes

Slide 56 · Krebs-cycle enzyme alterations can contribute to cancer

Fumarate hydratase (FH) and succinate dehydrogenase (SDH) as tumor suppressors.

Inherited loss-of-function is associated with predisposition to selected tumors.

The mechanisms remain incompletely resolved and may involve abnormal metabolites.

Slide 57 · Autophagy and oncometabolism are distinct concepts

Autophagy

Catabolic processing of intracellular material

Recycles metabolites under stress

May restrain or support tumors

Oncometabolism

Oncogenic effects of altered metabolite pathways

Enzyme mutations can create oncometabolites

Changes gene regulation and tumor behavior

Slide 58 · Mutant IDH produces an abnormal metabolite

Acquired mutant IDH activity

Production of 2-hydroxyglutarate

Inhibition of α-KG–dependent enzymes

Altered cell regulation

Mutant IDH acquires a neomorphic enzymatic function.

The aberrant product 2-hydroxyglutarate (2-HG) is an oncometabolite.

Slide 59 · 2-hydroxyglutarate perturbs epigenetic control

2-HG accumulation

TET-family inhibition

Altered DNA methylation

Misexpression of cancer genes

The text highlights TET2 as an affected α-ketoglutarate–dependent enzyme.

Abnormal methylation patterns provide one route to oncogenesis.

Slide 60 · IDH mutation creates a therapeutic target

Mutant IDH proteins differ structurally and functionally from normal IDH.

Drugs designed to inhibit mutant IDH selectively.

This example illustrates mechanism-driven cancer therapy, not a direct autophagy-targeted treatment.

Slide 61 · Two adaptations answer different cellular pressures

Cell seeking proliferation

Turns external glucose and glutamine into precursors

Requires oncogenic growth signaling

Builds biomass for division

Cell seeking persistence

Recycles internal proteins and organelles

Responds to nutrient and oxygen stress

Conserves viability while growth slows

Slide 62 · Case exercise: Starved nonmalignant cell

A nonmalignant cell is deprived of nutrients but remains viable for a limited period despite growth arrest.

Discussion prompts

Explain how autophagosomes and lysosomes contribute to viability.

Identify what is recycled and why this cannot sustain the cell forever.

Predict the consequence if this adaptation fails.

Slide 63 · Case exercise: Nutrient-limited residual tumor

Following treatment, a small population of cancer cells persists in a nutrient-limited environment without active proliferation.

Discussion prompts

Describe the putative role of autophagic recycling.

Explain why nondividing cells might escape treatments directed at proliferation.

State which part of this interpretation remains hypothetical.

Slide 64 · Interpretation of the dormant-tumor case

Autophagy may provide carbon sources that help dormant cells remain viable.

Low proliferation could reduce susceptibility to drugs acting mainly on dividing cells.

This as a plausible contributor to therapeutic failure, not an established universal rule.

Slide 65 · Common interpretive errors

Overstatement

More LC3 proves stronger recycling

Autophagy always kills tumor cells

All cancers have autophagy disabled

Dormancy guarantees drug resistance

Evidence-concordant statement

LC3 supports membrane-pathway assessment

Effects on tumors can be bidirectional

Regulatory wiring varies by tumor

Dormancy is a proposed persistence mechanism

Slide 66 · Mechanistic checkpoints for analysis

What stress exists?

Is autophagy induced?

Does lysosomal degradation proceed?

What is the cellular outcome?

Different questions address initiation, execution and biological impact.

A descriptive marker cannot by itself answer all four questions.

Slide 67 · Self-assessment: Resolve the paradox

Statement: “Autophagy is tumor suppressive; Therefore, inducing it always improves cancer control.”

Discussion prompts

Identify the part supported by Robbins.

Identify the missing tumor-specific qualifier.

Explain how dormancy changes the inference.

Slide 68 · Resolution: The outcome depends on context

Autophagy in cancer

Potentially restrains cancer

Some pro-autophagy genes are suppressors

Loss may favor tumor growth

Early protective role is plausible

Potentially sustains cancer

Metabolic salvage during hardship

Persistence of dormant cells

Possible contribution to treatment failure

Slide 69 · Integrated mechanism: Stress, recycling and fate

Environmental / metabolic stress

ATG-directed autophagosome

Lysosomal recycling

Context-dependent cell fate

Autophagy is a controlled recycling program.

In cancer, the biological consequence depends on regulatory wiring and state.

Slide 70 · Five statements to retain

Autophagy encloses cytoplasmic material and delivers it to lysosomes.

ATG-dependent membrane formation and LC3 lipidation organize sequestration.

Recycled metabolites support cells under nutrient deprivation or hypoxia.

Cancer may be restrained by autophagy loss-sensitive pathways or supported by stress recycling.

Dormancy makes simple treatment predictions unsafe.

Slide 71 · Primary references and source boundaries

Primary

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 7: Neoplasia, p. 269 — Autophagy.

Foundational

Same textbook, Chapter 2: Cell Injury, Cell Death, and Adaptations, pp. 34–35 — Autophagy and Figure 2.5.

Context

Same textbook, Chapter 1 — Intracellular Catabolism (Figure 1.10); Chapter 7, pp. 267–270 — Growth-Promoting Metabolic Alterations and Oncometabolism.